Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer

Urology

Volumn 84, Issue 2, 2014, Pages 373-379

  Kozminski, Michael A ^a   Palapattu, Ganesh S ^a   Mehra, Rohit ^a   Montgomery, Jeffrey S ^a   Weizer, Alon Z ^a   Skolarus, Ted A ^a   Hollenbeck, Brent K ^a   Miller, David C ^a   He, Chang ^a   Tomlins, Scott ^a   Montie, James E ^a   Feng, Felix Y ^a   Wood, David P ^b   Kunju, Lakshmi P ^a   Morgan, Todd M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; DOMINANT NODULE TO PROSTATE RATIO; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; UROGENITAL SYSTEM PARAMETERS;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR BURDEN;

EID: 84905105863     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.03.037     Document Type: Article

References (30)

1. C.R. Pound, A.W. Partin, and M.A. Eisenberger et al. Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
2. M. Han, A.W. Partin, and C.R. Pound et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565
3. M.R. Cooperberg, J.F. Hilton, and P.R. Carroll The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy Cancer 117 2011 5039 5046
4. E. Kikuchi, P.T. Scardino, and T.M. Wheeler et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 172 2004 508 511
5. M. Ates, D. Teber, and A.S. Gozen et al. Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis J Urol 177 2007 1771 1775 discussion 1775-1776
6. A.J. Stephenson, M.W. Kattan, and J.A. Eastham et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era J Clin Oncol 27 2009 4300 4305
7. B. Turkbey, and P.L. Choyke Multiparametric MRI and prostate cancer diagnosis and risk stratification Curr Opin Urol 22 2012 310 315
8. U. Capitanio, S. Ahyai, and M. Graefen et al. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer Urology 72 2008 1208 1211 discussion 1212-1203
9. T.A. Stamey, F.S. Freiha, and J.E. McNeal et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 3 Suppl 1993 933 938
10. K.H. Kim, S.K. Lim, and T.Y. Shin et al. Tumor volume adds prognostic value in patients with organ-confined prostate cancer Ann Surg Oncol 20 2013 3133 3139
11. S.P. Porten, M.R. Cooperberg, and P.R. Carroll The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease BJU Int 105 2010 472 475
12. R. Mizuno, J. Nakashima, and M. Mukai et al. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer BJU Int 104 2009 1215 1218
13. J.I. Epstein, M. Carmichael, and A.W. Partin et al. Is tumor volume an independent predictor of progression following radical prostatectomy? a multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup J Urol 149 1993 1478 1481
14. B.I. Chung, T.V. Tarin, and M. Ferrari et al. Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival Urol Oncol 29 2011 314 318
15. I.M. van Oort, J.A. Witjes, and D.E. Kok et al. Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer World J Urol 26 2008 237 241
16. C. Song, S. Seo, and H. Ahn et al. Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis Int J Clin Oncol 17 2012 355 360
17. S.A. Boorjian, M.K. Tollefson, and L.J. Rangel et al. Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy Prostate Cancer Prostatic Dis 15 2012 56 62
18. M.M. Merrill, B.R. Lane, and A.M. Reuther et al. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer Urology 70 2007 294 298
19. J.L. Bevilacqua, M.W. Kattan, and J.V. Fey et al. Doctor, what are my chances of having a positive sentinel node? a validated nomogram for risk estimation J Clin Oncol 25 2007 3670 3679
20. K.J. Van Zee, D.M. Manasseh, and J.L. Bevilacqua et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 2003 1140 1151
21. D.D. Davidson, M.O. Koch, and H. Lin et al. Does the size matter?: prostate weight does not predict PSA recurrence after radical prostatectomy Am J Clin Pathol 133 2010 662 668
22. F. Dong, J.S. Jones, and A.J. Stephenson et al. Prostate cancer volume at biopsy predicts clinically significant upgrading J Urol 179 2008 896 900 discussion 900
23. J.D. Davies, M.A. Aghazadeh, and S. Phillips et al. Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer J Urol 186 2011 2221 2227
24. M.R. Newton, S. Phillips, and S.S. Chang et al. Smaller prostate size predicts high grade prostate cancer at final pathology J Urol 184 2010 930 937
25. A.M. Wise, T.A. Stamey, and J.E. McNeal et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens Urology 60 2002 264 269
26. A.A. Renshaw, H. Chang, and A.V. D'Amico Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice Am J Clin Pathol 107 1997 704 708
27. S.J. Freedland, W.B. Isaacs, and E.A. Platz et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546 7554
28. T.A. Stamey, J.E. McNeal, and C.M. Yemoto et al. Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400
29. 3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy J Clin Oncol 16 1998 3094 3100
30. I.M. Thompson III, S. Salem, and S.S. Chang et al. Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods World J Urol 29 2011 15 20